Tag: Stingray Therapeutics
-
TGEN part of $2 million SBIR award to fund therapeutic development and testing
The Translational Genomics Research Institute (TGen), and Stingray Therapeutics, Inc. of Dallas and Houston, Texas announced a Small Business Innovation Research (SBIR) accelerated direct to phase II award of $2 Million.
